Which Treatment Offers Better Value for Your Journey?
Why Wegovy Pricing Appears Lower Than Mounjaro Initially
When comparing why Wegovy is cheaper than Mounjaro at first glance, the difference lies in their distinct dosing structures and starter doses. Wegovy begins with a 0.25mg dose at £79.99, designed as a gentle introduction to semaglutide treatment. This lower starting price reflects the medication's gradual dose escalation approach over 16 weeks. Mounjaro, containing tirzepatide, starts at 2.5mg with a different pricing structure that reflects its dual GIP and GLP-1 receptor mechanism. Both are prescription-only medicines requiring clinical assessment through our GPhC-registered pharmacy (#9012878).
The perceived cost difference between these treatments becomes more nuanced when considering the complete treatment pathway. Wegovy's escalation progresses through five doses: 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg maintenance, with pricing increasing at each stage. Understanding why Wegovy is cheaper than Mounjaro initially helps patients budget for their weight management journey. Both medications require prescription oversight and are designed to be used alongside a reduced-calorie diet and increased physical activity for optimal effectiveness.
Complete Pricing Structure: Wegovy vs Mounjaro Value Analysis
Analysing why Wegovy is cheaper than Mounjaro requires examining the full treatment cost over time. Wegovy single pen prices range from £79.99 (0.25mg starter) to £209.99 (2.4mg maintenance), whilst our bundle options provide convenience for multi-month supply. The Progress Duo (0.5mg & 1mg) costs £189.99, and our Ultimate Stability Trio (three 2.4mg pens) provides maintenance supply for £649.99. These prices reflect the final cost after applying discount codes FIRST40 (new customers) or DOSE25 (returning patients) at checkout.
When evaluating why Wegovy is cheaper than Mounjaro, consider that both treatments have different maintenance dose requirements and frequencies. Wegovy's once-weekly injection schedule at maintenance contrasts with Mounjaro's different dosing approach. Our transparent pricing structure ensures no hidden costs, with next-day cold-chain delivery included. Both treatments require ongoing prescription oversight, making the long-term value proposition dependent on individual response and maintenance requirements rather than initial pricing alone.
Clinical Evidence Behind Wegovy vs Mounjaro Effectiveness
Understanding why Wegovy is cheaper than Mounjaro involves examining their clinical foundations and mechanisms. Wegovy, containing semaglutide, demonstrated significant results in the STEP clinical trial programme, with patients achieving approximately 15% average weight loss at 68 weeks when used alongside diet and exercise modifications (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events among participants taking semaglutide.
Comparing why Wegovy appears cheaper than Mounjaro requires acknowledging their different clinical development pathways and mechanisms. Mounjaro's tirzepatide works as a dual GIP and GLP-1 receptor agonist, whilst Wegovy targets GLP-1 receptors specifically. Both treatments underwent rigorous clinical evaluation, though direct head-to-head comparisons weren't conducted due to different trial designs and populations. Individual responses vary, making clinical guidance essential for treatment selection.
How Wegovy's Mechanism Influences Its Pricing Structure
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural hormones regulating appetite and blood sugar. The medication binds to GLP-1 receptors in the brain, reducing appetite signals and promoting satiety after smaller meals. This mechanism may help reduce food cravings by affecting brain appetite centres, supporting weight management when combined with lifestyle modifications. Understanding how Wegovy works explains why its dose escalation starts gently at 0.25mg, allowing patients to adjust to the medication's effects. The gradual increase to the 2.4mg maintenance dose minimises potential side effects whilst optimising therapeutic benefits.
Streamlined Ordering Process for Both Wegovy and Mounjaro
Accessing either treatment through EverydayMeds begins with our 3-minute online clinical assessment, designed to gather essential medical history and weight management goals. Our qualified prescribers review applications within standard 3 working days, or 24 hours with express service, ensuring thorough evaluation before approving treatment. Once prescribed, we dispatch medications via next-day delivery using temperature-controlled packaging to maintain medication integrity. This process applies whether you're comparing why Wegovy is cheaper than Mounjaro or seeking guidance on treatment selection. Our clinical team remains available throughout your treatment journey, providing ongoing support and monitoring as required for these prescription-only medicines.
Storage and Practical Considerations: Wegovy vs Mounjaro
Wegovy offers practical advantages in storage flexibility, remaining stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy more convenient for travel or situations where refrigeration isn't immediately available. The FlexTouch pen delivery system provides precise dosing with each weekly injection, progressing through the mandatory escalation schedule over 16 weeks. Understanding these practical differences helps explain why some patients find Wegovy more convenient despite initial price comparisons. Both medications require refrigerated storage at 2-8°C before first use and should never be frozen.
Cost-Effectiveness Beyond Initial Pricing Comparisons
Determining why Wegovy is cheaper than Mounjaro extends beyond starter dose pricing to encompass treatment sustainability and maintenance costs. Wegovy's established dose escalation pathway provides predictable pricing structure, with maintenance therapy at 2.4mg representing the long-term cost consideration. Our bundle options, such as the Gentle Start Trio (£269.99) containing two 0.25mg pens and one 0.5mg pen, support patients taking a slower escalation approach. This flexibility in dosing progression may influence overall treatment costs depending on individual tolerance and response.
The true value comparison between Wegovy and Mounjaro involves considering treatment duration, effectiveness, and individual response rather than initial pricing alone. Both treatments require long-term commitment for sustained weight management, as clinical trials showed weight regain when treatment stops. EverydayMeds provides both options with identical service standards, allowing clinical guidance to determine optimal treatment rather than price being the sole deciding factor.
Expert Clinical Guidance and Treatment Selection
At EverydayMeds, our GPhC-registered clinical team (#9012878) evaluates each patient's suitability for either Wegovy or Mounjaro based on medical history, treatment goals, and individual circumstances rather than cost considerations alone. Both treatments are prescription-only medicines requiring careful assessment of BMI, weight-related comorbidities, and previous weight management attempts. We accept applications from patients with BMI ≥30, or BMI ≥27 with weight-related health conditions, following NICE guidelines for weight management interventions. Our prescribers can explain why Wegovy might be cheaper than Mounjaro initially whilst ensuring treatment selection prioritises clinical suitability and long-term success. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment with transparent pricing and expert medical oversight throughout your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
